• https://www.pharma-iq.com/events-sdmdglobal/

Attendance at SDMD Global 2020

February 7th, 2020|0 Comments

Attendance at SDMD Global 2020 Mr. Diarmuid Cahalane, Co-Founder & Director of Regulatory Affairs, Metabolomic Diagnostics will present at Software Design for Medical Devices Global (SDMD) forum in Berlin (17th -20th Feb 2020).    This [...]

METABOLOMIC DIAGNOSTICS ATTENDS SMFM PREGNANCY MEETING 2020

January 28th, 2020|0 Comments

Mr Charles Garvey, CEO of Metabolomic Diagnostics will be attending the Society of Maternal Fetal Medicine (SMFM) Pregnancy meeting next week in Texas, USA. The SMFM is a non-profit, membership organisation based in the [...]

MED IN IRELAND, RDS, DUBLIN

October 8th, 2019|0 Comments

Metabolomic Diagnostics are excited to be part of Med In Ireland this Thursday, 10th October at the RDS, Dublin Organised by Enterprise Ireland, Med in Ireland brings together innovative Irish medtech companies with healthcare providers [...]

EuroISHHP Conference 2019, Lund, Sweden

September 27th, 2019|0 Comments

Metabolomic Diagnostics are proud to sponsor the European International Society of the Study of Hypertension in Pregnancy (ISHHP) in Lund, Sweden next week. The theme of this year’s conference is “Thinking out of the box”. [...]

Codex4SMEs, Galway

September 18th, 2019|0 Comments

Mr. Diarmuid Cahalane, Co-Founder & Director of Metabolomic Diagnostics was one of the key speakers at the European Union, Interreg Project CODEX4SMEs conference in Galway last week.   WestBIC, CÚRAM and their European partners hosted [...]

Metabolomic Diagnostics to attend MSACL, Salzburg

September 17th, 2019|0 Comments

The Association for Mass Spectrometry Applications to the Clinical Lab (MSACL) 6th European meeting will take place in Salzburg, Austria later this month. MSACL provides a forum for discussing the clinical application of mass spectrometry [...]

Metabolomic Diagnostics QMS Certified to ISO 13485:2016

April 18th, 2019|0 Comments

CORK, Ireland April 19th, 2019. Metabolomic Diagnostics has today announced that its Quality Management system has successfully transitioned from ISO 13485: 2012 to ISO 13485:2016 following an audit by Certification Body, BQAI. This certification indicates [...]

Metabolomic Diagnostics to attend SRI, Paris

February 26th, 2019|0 Comments

Metabolomic Diagnostics’ CEO, Mr Charles Garvey and VP of R&D, Dr Robin Tuytten, PhD, will attend the 66th Annual Meeting of the Society for Reproductive Investigations (SRI) in Paris, France. “From Innovation to Impact” is [...]

Metabolomic Diagnostics appoints Marketing Manager

February 26th, 2019|0 Comments

We are pleased to announce the appointment of Mrs AnnMarie Barrett to the position of Marketing Manager at Metabolomic Diagnostics. Mrs Barrett is an experienced executive with over 20 years in the life science/biotechnology sector. [...]

METABOLOMIC DIAGNOSTICS ATTENDS SMFM

February 25th, 2019|0 Comments

Monday, February 4th 2019. Mr Charles Garvey, CEO of Metabolomic Diagnostics will be attending the Society of Maternal Fetal Medicine (SMFM) next week in Las Vegas. The SMFM is non-profit, membership organisation based in the [...]